Leptin and Coronary Heart Disease
Authors:
- Naveed SattarNaveed Sattar
- Goya WannametheeGWGoya Wannamethee
- Nadeem SarwarNSNadeem Sarwar
- Julia ChernovaJCJulia Chernova
- Debbie A. LawlorDebbie A. Lawlor
- Anne KellyAKAnne Kelly
- A. Michael WallaceAWA. Michael Wallace
- John DaneshJDJohn Danesh
- Peter H. WhincupPeter H. Whincup
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to comeBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- HyperleptinemiaHypertension, 2005
- Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanismsDiabetes, Obesity and Metabolism, 2004
- Plasma leptin and prognosis in patients with established coronary atherosclerosisJACC, 2004
- Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese womenInternational Journal of Obesity, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Coronary Heart Disease and Body Mass Index: A Systematic Review of the Evidence from Larger Prospective Cohort StudiesSeminars in Vascular Medicine, 2002
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- Lifestyle and Hemostatic Risk Factors for Ischemic Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2000